Immage Biotherapeutics Corp.

IMMG · OTC
Analyze with AI
8/31/2016
8/31/2015
9/30/2014
9/30/2013
Operating Activities
Net Income-$216-$0-$19-$0
Dep. & Amort.$9$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$8-$0$1$0
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$216-$0-$18-$12
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0$0$0
Financing Activities
Debt Repay.$11$0$0$0
Stock Issued$375$0$6$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6$0$1$14
Financing Cash Flow$380$0$13$14
Forex Effect$0-$0$0$0
Net Chg. in Cash$164-$0-$5$2
Supplemental Information
Beg. Cash$33$0$7$5
End Cash$197$0$2$7
Free Cash Flow-$216-$0-$18-$12